TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancerMay 30, 2020Breast CancerOncology
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancerMay 29, 2020Breast CancerOncology
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020COVID-19 UpdatesBreast CancerGastroenterologyMixed TopicsHematologyOncology
Home-based chemo skyrockets at one U.S. centerApril 10, 2020COVID-19 UpdatesBreast CancerGastroenterologyOncology
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020COVID-19 UpdatesBreast CancerGastroenterologyPreventive CareOncology
20% with cancer on checkpoint inhibitors get thyroid dysfunctionApril 2, 2020EndocrinologyOncologyBreast Cancer
No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerGastroenterologyPreventive CareOncology
Guidelines on delaying cancer surgery during COVID-19March 26, 2020COVID-19 UpdatesBreast CancerGastroenterologyOncology
Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020COVID-19 UpdatesBreast CancerOncology
CLL and breast cancer differ in the expression of regulatory microRNAsMarch 25, 2020Breast CancerOncologyHematology
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesBreast CancerGastroenterologyOncology
Study supports genetic testing for all breast cancer patients age 65 and youngerMarch 16, 2020Breast CancerWomen's Health
Abbreviated MRI bests digital breast tomosynthesis in finding cancer in dense breastsFebruary 27, 2020Breast CancerWomen's Health
